
Bristol-Myers reports negative results from Phase III study of Opdivo
Bristol-Myers Squibb Company has reported negative results from the Phase III CheckMate -331 trial of Opdivo.
Bristol-Myers Squibb Company has reported negative results from the Phase III CheckMate -331 trial of Opdivo.
Thank you for subscribing to Clinical Trials Arena